Always verify pricing and state availability on the provider's website before signing up.How our reviews work →
Strut Health vs Zealthy
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
8.1
Strut Health
Best for oral-lozenge compounded GLP-1 access★★★★☆4.1
Starting at $99/mo
CompoundedSemaglutideTirzepatideOral Lozenge Option
Visit Strut Health →4.8
Zealthy
Best for not currently recommended — listed for transparency and reader awareness only★★☆☆☆2.4
Starting at $286/mo
CompoundedSemaglutideTirzepatide
Visit Zealthy →Side-by-Side Comparison
| Feature | Strut Health | Zealthy |
|---|---|---|
| Overall Score | ✓8.1/10 | 4.8/10 |
| Starting Price | ✓$99/mo | $286/mo |
| Editorial Rating | ✓4.1 ★ /5 | 2.4 ★ /5 |
| Features | ✓6 features | 3 features |
| States Available | ✓49 | 34 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | ✓None | 2 warnings |
Pros & Cons
Strut Health
Pros
- ✓Both LegitScript and ACHC accreditation — pharmacy oversight standard most compounded GLP-1 providers don't advertise
- ✓Oral lozenge formulation available for semaglutide ($99/mo) and tirzepatide ($199/mo) — injection-free alternative
- ✓Transparent auto-refill pricing with 13–21% savings vs. one-off orders
- ✓Free unlimited follow-up messaging with board-certified US physicians
- ✓49 states covered (only Arkansas excluded as of September 2024)
Cons
- ✗'Medical necessity' eligibility gate — Strut's prescribers evaluate whether treatment is medically appropriate but the criteria are not publicly defined, so users can't self-screen before paying for a consultation
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
- ✗Pharmacy partners not publicly named — users can't independently verify 503A/503B compounding source
- ✗No insurance accepted — cash pay only
- ✗Phone consultation requirement varies by state (not every state mandates a synchronous visit)
Zealthy
Pros
- ✓34 states served — meaningful nationwide footprint
- ✓Asynchronous model removes friction for patients comfortable without a synchronous video visit
- ✓Independent licensed prescribers retain full clinical authority
Cons
- ✗TWO FDA warning letters for false/misleading marketing of compounded GLP-1s (Feb 2026 letter 717987 verified at fda.gov; September 2025 letter from secondary sources)
- ✗Active Novo Nordisk false-advertising lawsuit: Novo Nordisk A/S et al v. Zealthy Inc., case 1:25-cv-06391 (S.D.N.Y., filed 2025-08-04), alleging trademark infringement and marketing of compounded products as 'FDA-approved alternatives'
- ✗Active DOJ/FTC enforcement: United States v. Cerebral, Inc. et al, case 1:24-cv-21376 (S.D. Fla., amended complaint adding Zealthy Inc., Gronk Inc., founder Kyle Robertson, and others), alleging ROSCA violations (failure to disclose subscription terms, no informed consent for billing, locked cancellation), and unauthorized health-data sharing for targeted advertising
- ✗Founder pattern of conduct: Kyle Robertson previously founded Cerebral, which settled with the FTC in June 2024 ($5M consumer redress + $10M civil penalty suspended to $2M) for similar deceptive practices. Robertson then founded Zealthy and is alleged to have continued the same conduct
- ✗Company recently renamed FitRX/Zealthy to Gronk Inc. — rebrand pattern is itself a concerning signal in the context of active enforcement
- ✗Continued marketing of compounded semaglutide after FDA removed it from the shortage list on 2025-02-21 (post-shortage compounding without legal authorization)
- ✗Adds a $135/month membership fee on top of medication cost — total cash price is $286-$351/month
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
Our Verdict
Winner: Strut HealthScore: 8.1/10
Strut Health edges out Zealthy with a higher overall score of 8.1/10 and is particularly strong for oral-lozenge compounded GLP-1 access. Zealthy remains a solid alternative, especially if you're looking for not currently recommended — listed for transparency and reader awareness only.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.